Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8158645 | NOVARTIS | Compound, corresponding compositions, preparation and/or treatment methods |
Dec, 2024
(1 year, 8 months from now) |
Market Authorisation Date: 11 October, 2007
Treatment: NA
Dosage: CAPSULE;ORAL
6
United States
1
Israel
1
Russia
1
Argentina
1
Brazil
1
Japan
1
Morocco
1
South Africa
1
Canada
1
Australia
1
Korea, Republic of
1
Norway
1
Iceland
1
Taiwan, Province of China
1
China
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic